The β1-2-3-adrenoceptors (ADRB1, ADRB2 and ADRB3) genes encode the β-adrenoceptors, and their variants and/or epigenetic modifications are also associated with a high risk of MetS, leading to a genetic vulnerability during the stress response. This evidence concerns the gene ADRB2 and metabolic syndrome.